Partnership Opportunities in Drug Delivery (PODD) Announces Keynotes for the 8th Annual Event
NEW YORK (PRWEB) July 08, 2018 -- The Conference Forum announces the keynote-speaking faculty for the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference to be held at the Westin Copley Place in Boston on October 17-18, 2018.
Opening the 8th annual event with a year-in-review on new science, deals, and technologies is Roche’s Global Business Development Director for Roche Partnering Innovation and PODD Conference Chair, Barbara Lueckel, PhD.
David H Koch Institute Professor at MIT, Robert Langer, PhD will provide the opening annual keynote and will, for the first time, sit with veteran investor Amy Schulman to discuss what makes drug delivery technologies and deals successful as well as what unmet needs remain.
Ms Schulman has overseen Pfizer’s acquisition of Wyeth and led Pfizer’s large Consumer Healthcare business. She is the co-founder and CEO of Lyndra and venture Partner at Polaris Partners, and has also managed various start-ups focused on drug delivery systems.
Jeffrey Karp, PhD, Associate Professor of Medicine at Harvard Medical School and Director of the Laboratory for Accelerated Medical Innovation at Brigham and Women’s Hospital will provide the bioinspirational keynote. Dr Karp is a leading researcher in the fields of drug delivery, medical devices, stem cell therapeutics, and tissue adhesives.
Also keynoting is Justin Wright, PhD, Global Head of Innovation at Novartis. Dr Wright leads the drug development process for biologics and small molecules at Novartis. He has developed models and partnerships in drug delivery innovation and has commercialized drug delivery systems for the biotech, vaccine, and pharmaceutical industries.
“We are thrilled with the outstanding line up of some of the most influential thinkers in the drug delivery field and with the continual growth of PODD. We are happy to see how prominent this event has become in the industry,” noted Michelle McDermott, Conference Producer, PODD
The speaking faculty as of July 5th includes representation from GSK, Pfizer, BMS, Roche, Sanofi US, Allergan, Genentech, Merck, AstraZeneca, and Novartis.
PODD features an exhibit hall showcasing the widest range of products and solutions, as well as technology presentations from more than 45 companies covering:
- Injectable technologies
- Oral & transmucosal technologies
- Device technologies
- Ophthalmic technologies
- Transdermal & inhalation technologies
The event is an opportunity for large and small players in the drug delivery field to learn more about innovations and discover the most recent advancements across the field. PODD has a one-on-one partnering system to help facilitate business meetings and networking.
About Partnership Opportunities in Drug Delivery (PODD)
Partnership Opportunities in Drug Delivery (PODD) is a Boston based event designed to bring together technology innovators, pharmaceutical scientists, and industry executives to network and discuss the latest scientific advances in the drug delivery field. PODD is in its 8th year, chaired by Dr Barbara Lueckel of Roche, and exists with the goal to foster a meeting place that inspires innovation and advancement of novel drug delivery systems, as well as provide support for leaders behind the movement.
About the Conference Forum
The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance patient-centered clinical research and drug delivery systems.
Margaret Van Cleve, The Conference Forum LLC, http://theconferenceforum.org/, +1 (646) 9011688 Ext: 415, [email protected]
Share this article